CD274 and neoplasm: In relation to the subject of our study, tumor-infiltrating immune cells in urothelial cancers can express PD-L1 exhibiting immune downregulation, which should be taken into consideration when assessing what kind of cells—malignant or stromal—expresses PD-L1.